G. Chau

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial”.

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial

UNC Libraries(2020)10.17615/mnq7-rm09

N/A

0DataRank · unranked

0 citations

Myron S. Cohen, R. Panchia, Y. Zhang, M.A. Marzinke, R. Kofron +21 more

Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

UNC Libraries(2023)10.17615/2t00-0w43

N/A

0DataRank · unranked

0 citations

L. Cottle, A.Y. Liu, R. Kofron, D. Burns, S. Li +17 more

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

UNC Libraries(2023)10.17615/g6q4-an45

N/A

0DataRank · unranked

0 citations

Peter L. Anderson, Carrie Mathew, J.F. Rooney, L.R. Bushman, Juliet Mpendo +28 more